Release Date: 30/07/18 17:44 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 198.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%